(Q38324140)

2 September 2017

Regulation of NF-kappaB activity by I kappaB-related proteins in adenocarcinoma cells (English)

1 reference

2 September 2017

0 references

1 reference

E Dejardin

1

1 reference

2 September 2017

V Deregowski

2

1 reference

2 September 2017

M Chapelier

3

1 reference

2 September 2017

N Jacobs

4

1 reference

2 September 2017

J Gielen

5

1 reference

2 September 2017

M P Merville

6

1 reference

2 September 2017

V Bours

7

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

2 September 2017

1 reference

2 September 2017

18

1 reference

2 September 2017

2567-2577

1 reference

2 September 2017

16

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1202599

2 September 2017

0 references

cites work

Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

The NF-kappa B and I kappa B proteins: new discoveries and insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Differential regulation of NF-kappaB2(p100) processing and control by amino-terminal sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Regulation of major histocompatibility complex class I expression by NF-kappaB-related proteins in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Generation of p50 subunit of NF-kappa B by processing of p105 through an ATP-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Requirement for NF-kappaB in osteoclast and B-cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-kappa B subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Molecular interactions between HTLV-1 Tax protein and the NF-kappa B/kappa B transcription complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-kappaB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Negative interaction between the RelA(p65) subunit of NF-kappaB and the progesterone receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Human T-cell leukemia virus type I Tax-protein-mediated activation of NF-kappa B from p100 (NF-kappa B2)-inhibited cytoplasmic reservoirs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Bcl-3-mediated nuclear regulation of the NF-kappa B trans-activating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

A new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Transcriptional regulation of NF-kappa B2: evidence for kappa B-mediated positive and negative autoregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Molecular cloning and characterization of a novel Rel/NF-kappa B family member displaying structural and functional homology to NF-kappa B p50/p105.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

NF-kappaB2 is a putative target gene of activated Notch-1 via RBP-Jkappa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

The precursor of NF-kappa B p50 has I kappa B-like functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Role of IkappaBalpha ubiquitination in signal-induced activation of NFkappaB in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Effects on NF-kappa B1/p105 processing of the interaction between the HTLV-1 transactivator Tax and the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Structure, regulation and function of NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Distinct functional properties of IkappaB alpha and IkappaB beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Regulation of NFKB1 proteins by the candidate oncoprotein BCL-3: generation of NF-kappaB homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Regulation of IkappaBbeta degradation. Similarities to and differences from IkappaBalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

Cloning of a mitogen-inducible gene encoding a κB DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

7 January 2021

Persistent activation of NF-kappa B/Rel by human T-cell leukemia virus type 1 tax involves degradation of I kappa B beta.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

7 January 2021

Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

7 January 2021

Two distinct mechanisms contribute to the constitutive activation of RelB in lymphoid cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

7 January 2021

NF kappa B/I kappa B proteins. Their role in cell growth, differentiation and development. Madrid, Spain, July 7-10, 1996

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

7 January 2021

I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

7 January 2021

Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

7 January 2021

A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

7 January 2021

Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202599

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1202599

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference